Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.
Also called NCT01776788
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 156 participants
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Registry
-
NCT01776788
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01776788. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- insulin lispro injection, exenatide injection
- Intervention (Drug)
- insulin lispro injection
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
Record details
- Record id
cardio:ct-nct01776788- Content hash
e50ade43b3798bb21943f4b594ec27d713e0a30db0d02ae1712a000814c5b3d8